Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Exagen Inc (XGN)

Exagen Inc (XGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,130
  • Shares Outstanding, K 17,236
  • Annual Sales, $ 52,550 K
  • Annual Income, $ -23,690 K
  • 60-Month Beta 1.19
  • Price/Sales 0.47
  • Price/Cash Flow N/A
  • Price/Book 1.07
Trade XGN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.40
  • Number of Estimates 1
  • High Estimate -0.40
  • Low Estimate -0.40
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +9.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3003 +9.89%
on 04/16/24
1.8800 -23.99%
on 03/21/24
-0.3411 (-19.27%)
since 03/18/24
3-Month
1.3003 +9.89%
on 04/16/24
2.3888 -40.18%
on 01/30/24
-0.6311 (-30.64%)
since 01/18/24
52-Week
1.3003 +9.89%
on 04/16/24
3.9232 -63.58%
on 05/16/23
-1.0361 (-42.03%)
since 04/18/23

Most Recent Stories

More News
Veru Inc. (VERU) Reports Q2 Loss, Tops Revenue Estimates

Veru Inc. (VERU) delivered earnings and revenue surprises of -33.33% and 66.06%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

VERU : 1.4200 (+22.41%)
XGN : 1.4289 (+2.06%)
Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates

Quanterix Corporation (QTRX) delivered earnings and revenue surprises of 55.56% and 11.77%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

QTRX : 15.79 (+0.25%)
XGN : 1.4289 (+2.06%)
Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates

Exagen Inc. (XGN) delivered earnings and revenue surprises of 18.31% and 48.70%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

XGN : 1.4289 (+2.06%)
IMCC : 0.5900 (+4.74%)
High Tide Inc. (HITI) Reports Q1 Loss, Tops Revenue Estimates

High Tide Inc. (HITI) delivered earnings and revenue surprises of 28.57% and 6.13%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

HITI : 2.21 (-1.34%)
XGN : 1.4289 (+2.06%)
Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates

Exagen Inc. (XGN) delivered earnings and revenue surprises of 38.16% and 61.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

XGN : 1.4289 (+2.06%)
PDCO : 25.47 (-1.01%)
Azenta Announces Nomination of Tina S. Nova, Ph.D. and Dorothy E. Puhy to Board of Directors

/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Tina S. Nova, Ph.D. and Dorothy E. Puhy have been nominated for election to its Board of...

XGN : 1.4289 (+2.06%)
ABMD : 381.02 (+0.06%)
AZTA : 50.49 (-1.33%)
Warby Parker Inc. (WRBY) Q3 Earnings Match Estimates

Warby Parker Inc. (WRBY) delivered earnings and revenue surprises of 0% and 2.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

WRBY : 11.88 (-1.74%)
XGN : 1.4289 (+2.06%)
Quanterix Corporation (QTRX) Reports Q3 Loss, Tops Revenue Estimates

Quanterix Corporation (QTRX) delivered earnings and revenue surprises of 4.76% and 18.11%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

QTRX : 15.79 (+0.25%)
XGN : 1.4289 (+2.06%)
Agios Pharmaceuticals (AGIO) Reports Q3 Loss, Lags Revenue Estimates

Agios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of 14.86% and 29.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

AGIO : 29.43 (+1.38%)
XGN : 1.4289 (+2.06%)
Exagen Inc. (XGN) Q2 2022 Earnings Call Transcript

XGN earnings call for the period ending June 30, 2022.

XGN : 1.4289 (+2.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Exagen Inc. is engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases. It developed and commercialises testing products under AVISE brand. Exagen Inc. is based in Vista, California.

See More

Key Turning Points

3rd Resistance Point 1.5521
2nd Resistance Point 1.5010
1st Resistance Point 1.4650
Last Price 1.4289
1st Support Level 1.3779
2nd Support Level 1.3268
3rd Support Level 1.2908

See More

52-Week High 3.9232
Fibonacci 61.8% 2.9213
Fibonacci 50% 2.6117
Fibonacci 38.2% 2.3022
Last Price 1.4289
52-Week Low 1.3003

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar